SEC Form 4/A · accession 0001209191-18-001234
Intra-Cellular Therapies, Inc. · ITCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Robert L Van Nostrand
Director
Period of report
Dec 29, 2017
Accepted (ET)
Jan 3, 2018 · 6:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 29, 2017 | A | 345 | $14.48 | A | 3,656 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This amendment to Form 4 is filed solely to reflect that the correct Transaction Code for the reported transaction is "A".